Investigation of the SMARCB1 regulatory pathway regarding its role in maintaining stem cell and tumor characteristics, its potential as a biomarker, and its suitability as a target for personalized therapy in patients with Epithelioid Sarcoma (EpS)
Saved in:
| Description not available. |